Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy

Completed

Conditions studied: Prostate Cancer

In brief

RATIONALE: Gene mutations may make prostate cancer cells unable to attach to androgens. This may permit the growth of prostate cancer. Gene testing may improve the identification of patients with advanced prostate cancer. PURPOSE: Clinical trial to study the androgen receptor gene in patients with prostate cancer that is not responsive to hormone therapy.

Key facts

Study ID
NCT00002924
Run by
Alliance for Clinical Trials in Oncology
People needed
184
Starts
1997-01-01
Expected to finish
2006-06-01
Last updated by the study team
2016-07-14

Who can join

Age: any. Sex: male. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.